KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Rigel Pharmaceuticals (RIGL) over the last 12 years, with Q3 2025 value amounting to $45.9 million.

  • Rigel Pharmaceuticals' Receivables - Net rose 5020.44% to $45.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.9 million, marking a year-over-year increase of 5020.44%. This contributed to the annual value of $41.6 million for FY2024, which is 3621.93% up from last year.
  • Latest data reveals that Rigel Pharmaceuticals reported Receivables - Net of $45.9 million as of Q3 2025, which was up 5020.44% from $39.9 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Receivables - Net registered a high of $142.2 million during Q1 2021, and its lowest value of $3.0 million during Q1 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' median Receivables - Net value was $23.5 million (recorded in 2023), while the average stood at $30.5 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first skyrocketed by 137199.79% in 2021, then tumbled by 8928.23% in 2022.
  • Rigel Pharmaceuticals' Receivables - Net (Quarter) stood at $15.5 million in 2021, then increased by 29.27% to $20.0 million in 2022, then soared by 52.75% to $30.6 million in 2023, then soared by 36.22% to $41.6 million in 2024, then rose by 10.36% to $45.9 million in 2025.
  • Its Receivables - Net was $45.9 million in Q3 2025, compared to $39.9 million in Q2 2025 and $3.0 million in Q1 2025.